Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
In this round-up, the growth of novel coronavirus (Covid-19) infections outside China outpaced that reported by the country, Chinese regulators announced more loosening policies and the trade of wild animals for consumption is banned in the Mainland. -
Leveraged finance investors are no shrinking violets, and held out longer than most against the rising pessimism caused by the coronavirus. But by Thursday, it was even giving high yield and leveraged loan players a sinking feeling.
-
Workers of the world’s capital markets united this week in efforts to keep the funding flowing as the threat of the Covid-19 coronavirus advances. Roadshows, mandate pitches and even quotidian office life faced emergency changes as embattled financiers braced themselves and their businesses for virus disruption.
-
Coronavirus fears loomed over an otherwise benign SFVegas conference this week, with concerns over a pandemic trickling particularly into the aircraft segment. Sources say tangible cracks are beginning to show, with one deal shelved and spreads widening dramatically in the last week.
-
The worsening of the Covid-19 outbreak has battered equity prices and sent investors scurrying for the safety of core government bonds. Most primary markets are all but shuttered, and investors are praying for central banks to provide a glimmer of hope.
-
Market participants should be braced for political volatility as the world comes close to experiencing a pandemic.
